Antihyperlipidemic Drugs Market
According to Intent Market Research, the Antihyperlipidemic Drugs Market is expected to grow from USD 13.9 billion in 2023 at a CAGR of 5.9% to touch USD 20.8 billion by 2030. The Antihyperlipidemic Drugs Market is dominated by key players such as Pfizer Inc., Merck & Co., Inc., Novartis AG, AstraZeneca, Amgen Inc., Sanofi S.A., AbbVie Inc., GlaxoSmithKline (GSK), Takeda Pharmaceutical Company, Bayer AG, Johnson & Johnson, Bristol Myers Squibb, Eli Lilly and Company, Daiichi Sankyo Co., Ltd., Regeneron Pharmaceuticals.